T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Tractor Supply
TSCO
$18.9B
| $204M | 0.02% |
4,277,530
-182,625
| -4% | -$7.99M |
|
552
Gibraltar Industries
ROCK
$1.47B
| $202M | 0.02% |
3,036,618
-111,544
| -4% | -$7.96M |
|
|
VMEO
553
DELISTED
Vimeo
VMEO
| $202M | 0.02% |
11,227,946
-7,095,845
| -39% | -$173M |
|
|
AMED
554
DELISTED
Amedisys
AMED
| $201M | 0.02% |
1,242,446
-29,940
| -2% | -$4.81M |
|
555
MaxLinear
MXL
$7.09B
| $200M | 0.02% |
2,655,248
-31,064
| -1% | -$1.99M |
|
556
AES
AES
$10.5B
| $200M | 0.02% |
8,222,817
-1,520,018
| -16% | -$36.9M |
|
557
AngloGold Ashanti
AU
$48.2B
| $200M | 0.02% |
9,509,823
+4,321,799
| +83% | +$84.2M |
|
558
Gilead Sciences
GILD
$170B
| $198M | 0.02% |
2,729,876
-854,995
| -24% | -$58.9M |
|
559
Grab
GRAB
$14.7B
| $197M | 0.02% |
+28,468,485
| New | +$217M |
|
560
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.66B
| $196M | 0.02% |
2,045,635
| – | – |
|
561
iShares MSCI India ETF
INDA
$6.58B
| $196M | 0.02% |
4,272,423
+713,410
| +20% | +$34.5M |
|
|
CERE
562
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $195M | 0.02% |
6,000,922
+160,191
| +3% | +$5.65M |
|
563
Banco Santander Chile
BSAC
$16B
| $194M | 0.02% |
11,902,519
-561,702
| -5% | -$10.1M |
|
564
StepStone Group
STEP
$4.06B
| $193M | 0.02% |
4,640,292
-45,093
| -1% | -$1.99M |
|
565
The Ensign Group
ENSG
$10.6B
| $192M | 0.02% |
2,284,127
-41,348
| -2% | -$3.21M |
|
566
Globant
GLOB
$1.67B
| $192M | 0.02% |
610,028
-46,046
| -7% | -$13.6M |
|
567
West Fraser Timber
WFG
$5.51B
| $191M | 0.02% |
2,000,466
+11,920
| +0.6% | +$1.03M |
|
568
Capri Holdings
CPRI
$1.79B
| $190M | 0.02% |
2,929,614
+697,277
| +31% | +$41.3M |
|
569
Pool Corp
POOL
$7.24B
| $190M | 0.02% |
335,678
-27,586
| -8% | -$14.5M |
|
570
WEC Energy
WEC
$35.7B
| $189M | 0.02% |
1,951,486
-509,412
| -21% | -$46.6M |
|
|
NVRO
571
DELISTED
NEVRO CORP.
NVRO
| $189M | 0.02% |
2,328,531
-2,343,234
| -50% | -$235M |
|
|
XIFR
572
XPLR Infrastructure LP
XIFR
$1.08B
| $187M | 0.02% |
2,220,612
-68,644
| -3% | -$5.74M |
|
573
Progressive
PGR
$121B
| $187M | 0.02% |
1,825,043
-493,015
| -21% | -$47.1M |
|
574
Matsons
MATX
$6.44B
| $187M | 0.02% |
2,078,714
-263,476
| -11% | -$22.5M |
|
575
Ollie's Bargain Outlet
OLLI
$4.61B
| $186M | 0.02% |
3,637,859
+527,752
| +17% | +$32.1M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.